When Does AI-Assisted Medication Review Add Clinical Value? An Evidence-Mapping Review of Prescription Screening, Automation Error, Verification Workload, Pharmacist Oversight, and Patient-Level Consequences, 2017–2026
Year: 2026
Type: article
Abstract: Artificial intelligence is increasingly used to prioritize prescriptions, suppress low-value alerts, identify medication-error risk, and support pharmacist verification. However, technical detection performance is frequently discussed alongside workflow or patient outcomes as though these endpoints demonstrate equivalent clinical value. This evidence-mapping review examines where AI-assisted medication review has progressed beyond technical screening and where evidence remains limited across aut
DOI: 10.51847/nrvbaxjhib
Authors: Ahmed Ben Ali, Samira Gharbi, Nabil Jebali
Institutions: Tunis University, University of Sfax
Language: English
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7213656100
